Meiotic regulation of the CDK activator RINGO/Speedy by ubiquitin-proteasome-mediated processing and degradation

Gustavo J Gutierrez1, Andrea Vögtlin, Ana Castro

  • 1EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany. gustavo@burnham.org

Nature Cell Biology
|September 12, 2006
PubMed

Insights

Xenopus RINGO/Speedy (XRINGO) protein levels are tightly regulated during oocyte maturation through processing and degradation. This control is essential for meiotic progression and cell cycle transitions in Xenopus oocytes.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • Xenopus RINGO/Speedy (XRINGO) is a key regulator of oocyte meiotic maturation.
  • XRINGO directly activates cyclin-dependent kinases Cdk1 and Cdk2, crucial for cell cycle progression.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling endogenous XRINGO protein levels during Xenopus oocyte meiosis.
  • To elucidate the roles of XRINGO processing and degradation in meiotic progression and cell cycle transitions.

Main Methods:

  • Analysis of endogenous XRINGO protein accumulation and downregulation during oocyte maturation.
  • Identification of ubiquitination and proteasomal degradation pathways involved in XRINGO regulation.
  • Investigation of the role of specific kinases and ubiquitin ligases (SCF(betaTrCP), Siah-2) in XRINGO processing and degradation.

Main Results:

  • Endogenous XRINGO protein exhibits transient accumulation during meiosis I entry, followed by downregulation.
  • XRINGO processing involves SCF(betaTrCP)-mediated ubiquitination and proteasomal degradation, generating an N-terminal fragment.
  • Kinases like PKA and GSK-3beta stimulate XRINGO processing, potentially maintaining G2 arrest.
  • Siah-2-mediated degradation of XRINGO, likely via phosphorylation at Ser 243, is important for S phase omission between meiosis I and II.

Conclusions:

  • XRINGO expression is precisely controlled by interconnected processing and degradation pathways.
  • These regulatory mechanisms are critical for timely meiotic progression and cell cycle events, such as S phase omission, in Xenopus oocytes.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...